Market Analysis: Nifty Recovery and Key Stock Picks
The Indian stock market concluded the recent week with positive momentum, as benchmark indices recorded gains. The Nifty index rose by 2% to reach 23,053.10, while the Sensex climbed 1.8% to 74,459.53. This upward movement was largely supported by buying activity in the IT, healthcare, and select financial sectors. Conversely, the Bank Nifty index showed more muted performance, advancing by only 0.6%.
Institutional activity provided a constructive backdrop for this recovery. Foreign Institutional Investors (FIIs) were net buyers, recording purchases of ₹6,304.67 crore in the cash market, while Domestic Institutional Investors (DIIs) contributed with net purchases of ₹3,109.79 crore. Despite these inflows, market observers note that a single week of foreign buying is insufficient to fully reverse the selling trends observed throughout October. Ongoing variables, such as geopolitical tensions and fluctuating crude oil prices, continue to create uncertainty regarding inflation and corporate costs.
Sumeet Bagadia, Executive Director at Choice Broking, notes that the Nifty 50 index faces a capped immediate upside as it has yet to reclaim its 50-day Exponential Moving Average (EMA) near 23,160. The index currently faces a crucial resistance zone between 23,150 and 23,200, with immediate support identified in the 22,800 to 22,900 range. While the daily bullish candle and an RSI of 53.50 suggest strengthening short-term momentum, the broader market remains sensitive to global indicators.
The Bank Nifty remains in a weaker technical position, trading below its 20-day and 50-day EMAs, which currently serve as resistance levels. A sustained recovery for this index would require it to move above 55,000. In terms of individual stock recommendations, Bagadia has highlighted three specific equities showing positive technical setups: Sun Pharma, IndiGo, and Infosys.
Context/Analysis: For investors, the current market environment suggests a cautious optimism. While technical indicators like the RSI and the Put-Call Ratio (PCR) of 1.24 point toward a positive derivatives setup, the inability of the Nifty to clear its 50-day EMA suggests that a breakout is not yet confirmed. The focus for the coming week should remain on whether the index can consolidate above its support levels or if external macroeconomic pressures, such as oil prices, force a retest of lower bounds. The specific focus on IT and healthcare stocks, as seen in the picks for Infosys and Sun Pharma, reflects a rotation into sectors that are currently demonstrating better technical strength compared to the broader banking sector.
Why it matters
The market recovery, supported by institutional inflows and specific sector strength, provides a critical test of whether indices can break through key moving average resistance levels amid ongoing global economic uncertainty.
FAQ
What are the recommended stocks for Monday?
Sumeet Bagadia has recommended Sun Pharma, IndiGo, and Infosys.
What is the current technical status of the Nifty 50?
The Nifty 50 is facing resistance at 23,150–23,200 and has support at 22,800–22,900, with the index needing to reclaim its 50-day EMA at 23,160 to strengthen its recovery.
How did institutional investors perform during the week?
FIIs were net buyers of ₹6,304.67 crore, and DIIs were net buyers of ₹3,109.79 crore.
Source: Mint Markets. See the original source for full details.
Scan with your phone
Scan with your phone